Company Description
Elan has brains on its mind. The company is focused on the development of pharmaceuticals for neurological and autoimmune diseases, as well as for...
Key Elan Financials
| Company Type | Public - NYSE: ELN; Irish: ELA Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $759.4 |
| 2006 Employees | 1,734 |
More Elan Financials (11 pages)
Competition
Competitive Landscape for Biotechnology Sector
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Elan's competition across multiple industries
Top Elan Competitors
Sponsored Links
The Business Directory
Elan Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Kyran McLaughlin | Network | E-mail |
| President, CEO, and Director | G. Kelly Martin | Network | E-mail |
| EVP, CFO, and Director | Shane M. Cooke | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Elan News
- R. Glendinning 2d, 75, executive [Philadelphia Inquirer (PA)] (10 Oct 2008 04:00:00 EDT)
- Obituaries [Pantagraph (Bloomington, IL)] (10 Oct 2008 04:00:00 EDT)
- GAMMA RADIATION STERILIZED NANOPARTICULATE DOCETAXEL COMPOSITIONS AND METHODS FOR MAKING THE SAME [PCT Biblio Info] (09 Oct 2008 11:22:00 EDT)
Sponsored Opportunity
